A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

EuroIntervention 2016;12:e1413-e1419 published online e-edition December 2016. DOI: 10.4244/EIJ-D-15-00511

Christoph Naber
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Hüseyin Ince2,3, MD; Peter Frambach4, MD; Antonio Colombo5, MD; Christian Butter6, MD; Fernando Gatto7, MD; Ulrich Hink8, MD; Georg Nickenig9, MD; Giuseppe Bruschi10, MD; Guus Brueren11, MD; Didier Tchétché12, MD; Peter Den Heijer13, MD; Wolfgang Schillinger14, MD; Smita Scholtz15, MD; Jan Van der Heyden16, MD, PhD; Thierry Lefèvre17, MD; Martine Gilard18, MD; Karl-Heinz Kuck19
1. Contilia Heart and Vascular Centre, Elisabeth-Krankenhaus Essen, Essen, Germany; 2. Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, Germany; 3. Universitätsklinikum Rostock, Rostock, Germany; 4. Institut de Chirurgie Cardiaque et de Cardiolog

Aims: Our aim was to assess the clinical outcomes of the Direct Flow Medical Transcatheter Aortic Valve System (DFM-TAVS), when used in routine clinical practice.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

repositionabilityretrievabilitysevere aortic valve stenosistranscatheter aortic valve implantation
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Early experience with the Occlutech PLD occluder for mitral paravalvar leak closure through a hybrid transapical approach

Latest news